Legal Representation
Attorney
Michael J. Leonard
USPTO Deadlines
Next Deadline
2024 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250826)
Due Date
August 26, 2031
Grace Period Ends
February 26, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
34 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 26, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 26, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 10, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 10, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 4, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 29, 2024 | OTHE | I | CASE RETURNED TO EXAMINATION | Loading... |
| Nov 29, 2024 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| Oct 29, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 14, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 29, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 29, 2024 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jan 10, 2024 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Aug 29, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| May 30, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| May 30, 2023 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| May 30, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| May 25, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 25, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 25, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 25, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 9, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 9, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 9, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 19, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 19, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 19, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 18, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 2, 2022 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Mar 1, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 26, 2022 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Feb 11, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 10, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Cells for scientific, laboratory or medical research
Class 005
Pharmaceutical preparations for use in cell therapy for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy, immunology, and oncology; biological preparations for the identification and treatment of cancer and oncological conditions; Cells for medical use, namely, cells for use in creating cell therapies for the treatment of medical conditions
Class 040
Biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process
Class 042
laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, biological and biotechnological substances and biomanufacturing; Development and test of chemical production methods for pharmaceuticals; Pharmaceutical research and development; biotechnological services, namely, biotechnological analysis and research services in the field of cellular therapeutics
Class 044
Providing medical services in the nature of adoptive cell therapy; Stem cell therapy services; Personalized stem cell therapy services for the treatment of cancer; Stem cell therapy services and treatments containing cells, and lymphocytes for medical and clinical use
Classification
International Classes
001
005
040
042
044